73.3301
92.4739
1
1 Lakh
Investment declined to₹ 10000
Monthly SIP Declined toSuitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Axis NIFTY Healthcare ETF-G | -8.64 | 0.17 | -0.19 | 3.27 | 4.22 | -1.50 | -8.95 | -- | -- | -- | -- |
| S&P BSE Healthcare TRI | -10.66 | 0.20 | 0.35 | 3.25 | 3.13 | -2.80 | -10.64 | -- | -- | -- | -- |
| Equity: Sectoral-Pharma | -9.58 | 0.03 | 0.11 | 2.59 | 3.58 | -1.80 | -8.94 | -- | -- | -- | -- |
| Rank within category | 7 | 5 | 13 | 4 | 6 | 8 | 8 | -- | -- | -- | -- |
| Number of funds in category | 15 | 16 | 16 | 15 | 15 | 15 | 13 | 9 | 4 | 3 | 3 |
As on 17-Aug-2022
| Fund name | Rating | Launch Date | 1-Year Return | 3-Year Return | 5-Year Return | Expense Ratio | Assets (Cr) |
|---|---|---|---|---|---|---|---|
| Axis NIFTY Healthcare ETF | May-21 | -8.95 | -- | -- | 0.22 | 21 | |
| Nippon India Pharma Fund | Jun-04 | -9.56 | 26.64 | 17.90 | 1.98 | 4,620 | |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | Invest Now | Jul-18 | -8.44 | 26.65 | -- | 2.07 | 2,503 | |
| Mirae Asset Healthcare Fund - Regular Plan | Invest Online | Jul-18 | -7.29 | 29.93 | -- | 2.10 | 1,738 | |
| SBI Healthcare Opportunities Fund | Invest Online | Jul-99 | -6.92 | 25.70 | 12.25 | 2.18 | 1,668 |
| Best Performance | Worst Performance | |||
|---|---|---|---|---|
| Return (%) | Period | Return (%) | Period | |
| Week | 6.77 | 07-Mar-2022 - 14-Mar-2022 | -7.05 | 02-May-2022 - 10-May-2022 |
| Month | 9.12 | 07-Mar-2022 - 06-Apr-2022 | -10.87 | 12-Apr-2022 - 12-May-2022 |
| Quarter | 8.98 | 04-Jun-2021 - 03-Sep-2021 | -14.01 | 17-Mar-2022 - 17-Jun-2022 |
| Year | -5.43 | 21-May-2021 - 23-May-2022 | -14.72 | 02-Jul-2021 - 04-Jul-2022 |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| Axis NIFTY Healthcare ETF-G | -- | -- | -- | -- | -- | -- |
| S&P BSE Healthcare TRI* | 22.78 | 22.44 | 0.86 | 1.63 | -- | -- |
| Equity: Sectoral-Pharma* | 23.87 | 20.45 | 1.00 | 1.96 | 0.89 | 3.20 |
| Rank within category | -- | -- | -- | -- | -- | -- |
| Number of funds in category | -- | -- | -- | -- | -- | -- |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on
* As on 31-Jul-2022
Please wait...
| Number of Stocks | 20 |
| Top 10 Stocks (%) | 82.03 |
| Top 5 Stocks (%) | 64.19 |
| Top 3 Sectors (%) | 99.76 |
| Portfolio P/B Ratio | 4.40 |
| Portfolio P/E Ratio | 36.12 |
| Fund | Category | |
|---|---|---|
| Average Mkt Cap (Rs Cr) | 68,417 | 56,506 |
| Giant (%) | 22.11 | 20.17 |
| Large (%) | 45.51 | 35.87 |
| Mid (%) | 30.57 | 36.51 |
| Small (%) | 1.80 | 7.35 |
| Tiny (%) | -- | 0.54 |
Please wait...
| Company | Sector | P/E | 3Y High | 3Y Low | % Assets | |
|---|---|---|---|---|---|---|
|
Sun Pharmaceutical Industries | Healthcare | 56.51 | 22.06 | 14.35 | 22.06 |
|
|
Cipla | Healthcare | 33.50 | 11.50 | 9.05 | 11.48 |
|
|
Dr. Reddy's Lab | Healthcare | 23.51 | 13.17 | 10.45 | 10.73 |
|
|
Divi's Laboratories | Healthcare | 32.01 | 13.67 | 10.27 | 10.58 |
|
|
Apollo Hospitals | Healthcare | 69.51 | 11.67 | 6.58 | 9.34 |
|
|
Laurus Labs | Healthcare | 37.88 | 5.19 | 4.05 | 4.45 |
|
|
Alkem Laboratories | Healthcare | 26.84 | 3.69 | 2.56 | 3.43 |
|
|
Lupin | Healthcare | -- | 6.01 | 3.34 | 3.37 |
|
|
Aurobindo Pharma | Healthcare | 14.24 | 5.80 | 3.32 | 3.32 |
|
|
Torrent Pharmaceuticals | Healthcare | 66.12 | 3.27 | 2.73 | 3.27 |
|
|
Biocon | Healthcare | 53.30 | 3.72 | 3.04 | 3.04 |
|
|
Ipca Laboratories | Healthcare | 32.57 | 3.33 | 2.74 | 2.97 |
|
|
Abbott India | Healthcare | 49.96 | 2.31 | 0.00 | 2.31 |
|
|
Zydus Lifesciences | Healthcare | 9.03 | 3.25 | 1.85 | 1.93 |
|
|
Dr. Lal Pathlabs | Healthcare | 77.69 | 2.51 | 1.52 | 1.62 |
|
|
Syngene International | Healthcare | 60.80 | 1.50 | 0.00 | 1.43 |
|
|
Pfizer | Healthcare | 43.32 | 1.77 | 1.40 | 1.42 |
|
|
Glenmark Pharma. | Healthcare | 13.62 | 1.92 | 1.21 | 1.21 |
|
|
Granules India | Healthcare | 19.22 | 0.95 | 0.00 | 0.92 |
|
|
Metropolis Healthcare | Healthcare | 43.16 | 1.76 | 0.00 | 0.88 |
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 31-Jul-2022
— Jinesh Gopani since 30-Apr-2021
Education: Mr. Gopani is a B. Com (H) and MMS from Bharati Vidyapeeth Institute of Management Studies and Research.
Experience: Prior to joining Axis AMC he has worked with Birla Sun Life AMC, Voyager India Capital Pvt. Ltd., Emkay Shares & Stock Brokers Limited and Net worth Stock Broking Limited.
Interviews:
Funds Managed:
The scheme seeks to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors.
| Min. Investment (₹) | 5,000 |
| Min. Addl Investment (₹) | -- |
| Min. SIP Investment (₹) | -- |
| Min. No of Cheques | -- |
| Min. Withdrawal (₹) | -- |
| Min. Balance (₹) | -- |
| Lock-in Period | Not Applicable |
| Exit Load | 0 |
| Fund House: | Axis Mutual Fund |
| Launch Date: | 17-May-2021 |
| Return Since Launch: | -1.74% |
| Benchmark: | NIFTY Healthcare TRI. |
| Riskometer: | Very High |
| Type: | Open-ended |
| Assets: | ₹ 21 Cr (As on 31-Jul-2022) |
| Expense Ratio: | 0.22% (As on 31-Jul-2022) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | -- |
AMC: Axis Asset Management Company Ltd.
Address: "Axis House" - 1st Floor, C-2 - Wadia International Centre, Pandurang Budhkar Marg , Worli, Mumbai - 400025
Phone: 022-24255161
Fax: 022-43255199
Website: http://www.axismf.com
Registrar & Transfer Agent: KFin Technologies Ltd.
Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016
Phone: 040-44857874
Email: [email protected]
Website: www.karvymfs.com
You have reserved a spot
Fri, 19-Aug-2022
12:30 PM - 12:40 PM